Alk Abello Drug Patent Portfolio
Alk Abello owns 1 orange book drug protected by 8 US patents Given below is the list of Alk Abello's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US11246863 | Ciprofloxacin otic composition and kits and method for using same | 27 Nov, 2038 | Active |
US11040004 | Otic gel formulations for treating otitis externa | 12 Nov, 2037 | Active |
US9220796 | Sterilization of ciprofloxacin composition | 01 Jul, 2035 | Active |
US8318817 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 27 Apr, 2030 | Active |
US9233068 | Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders | 11 Dec, 2029 | Active |
US11369566 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 21 Apr, 2029 | Active |
US9205048 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 21 Apr, 2029 | Active |
US9603796 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 21 Apr, 2029 | Active |
Latest Legal Activities on Alk Abello's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Alk Abello.
Activity | Date | Patent Number |
---|---|---|
Expire Patent
Critical
| 05 Feb, 2024 | US9220796 |
Expire Patent
Critical
| 15 Jan, 2024 | US9205048 |
Maintenance Fee Reminder Mailed
Critical
| 21 Aug, 2023 | US9220796 |
Maintenance Fee Reminder Mailed
Critical
| 31 Jul, 2023 | US9205048 |
Recordation of Patent Grant Mailed
Critical
| 28 Jun, 2022 | US11369566 |
Patent Issue Date Used in PTA Calculation
Critical
| 28 Jun, 2022 | US11369566 |
Email Notification
Critical
| 09 Jun, 2022 | US11369566 |
Issue Notification Mailed
Critical
| 08 Jun, 2022 | US11369566 |
Application Is Considered Ready for Issue
Critical
| 31 May, 2022 | US11369566 |
Dispatch to FDC | 31 May, 2022 | US11369566 |
Email Notification
Critical
| 31 May, 2022 | US11369566 |
Mail Response to 312 Amendment (PTO-271)
Critical
| 31 May, 2022 | US11369566 |
Response to Amendment under Rule 312
Critical
| 25 May, 2022 | US11369566 |
Pubs Case Remand to TC
Critical
| 19 May, 2022 | US11369566 |
Supplemental Papers - Oath or Declaration | 18 May, 2022 | US11369566 |
Alk Abello's Family Patents
Alk Abello Drug List
Given below is the complete list of Alk Abello's drugs and the patents protecting them.
1. Otiprio
Otiprio is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US11246863 | Ciprofloxacin otic composition and kits and method for using same |
27 Nov, 2038
(13 years from now)
| Active |
US11040004 | Otic gel formulations for treating otitis externa |
12 Nov, 2037
(12 years from now)
| Active |
US9220796 | Sterilization of ciprofloxacin composition |
01 Jul, 2035
(10 years from now)
| Active |
US8318817 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
27 Apr, 2030
(5 years from now)
| Active |
US9233068 | Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders |
11 Dec, 2029
(4 years from now)
| Active |
US11369566 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
21 Apr, 2029
(4 years from now)
| Active |
US9205048 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
21 Apr, 2029
(4 years from now)
| Active |
US9603796 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
21 Apr, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Otiprio's drug page